PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer
ConclusionOur study suggests that PRMT5 may play an important role in the doxorubicin resistance of breast cancer.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Epithelial Cancer | Stem Cell Therapy | Stem Cells | Study